Viewing Study NCT00375505


Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2026-01-25 @ 8:28 AM
Study NCT ID: NCT00375505
Status: COMPLETED
Last Update Posted: 2015-09-07
First Post: 2006-09-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None Premenopausal View
None Bone mineral density View
None Cancer therapy induced bone loss View
None zoledronic acid View